Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

C225 effective in mouse model of human bladder cancer

April 16, 1997

ImClone reports research results from its anti-flk-1 monoclonal antibody program

April 16, 1997

Oxford Molecular Group and ImmunoGen join efforts in humanized antibody development

April 16, 1997

DiagnoCure licenses growth factor derivatives for cancer diagnosis/therapy

April 16, 1997

Pola discloses antitumor/immunosuppressive agents

April 16, 1997

Antitumor indane derivatives from Taiho

April 16, 1997

Nippon Kayaku isolates novel antitumor agents

April 16, 1997

Natural interferon gamma introduced in Japan

April 15, 1997

TGF-beta1 antisense vaccine effective in rat prostate cancer model

April 15, 1997

In vitro antitumor activity of lactoferrin

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...